Table 3.
The frequency of HPV and EBV in four study groups
| Group |
Malignant tumor (n=68 )
|
Borderline tumor
(n=27 ) |
Benign tumor
(n= 65 ) |
Normal group
(n=45 ) |
P-value | ||||
|---|---|---|---|---|---|---|---|---|---|
| Total | Grade I(n=31 ) | Grade II(n=14 ) | Grade III(n=23 ) | ||||||
| HPV | Total | 13 (19.1%) |
3 (9.7%) |
3 (21.4%) |
7 (30.4%) |
6 (22.2%) |
3 (4.6%) |
0 (0%) |
0.002 |
| HPV16 | 5 (7.4%) |
1 (3.2%) |
1 (7.1%) |
3 (13%) |
0 (0%) |
0 (0%) |
0 (0%) |
||
| HPV18 | 12 (17.6%) |
3 (9.7%) |
2 (14.3%) |
7 (30.4%) |
4 (14.8%) |
2 (3.1%) |
0 (0%) |
||
| HPV 16/18 |
4 (5.9%) |
1 (3.2%) |
1 (7.1%) |
2 (8.7%) |
0 (0%) |
0 (0%) |
0 (0%) |
||
| EBV | 7 (10.3%) |
2 (6.4%) |
0 (0%) |
5 (21.7%) |
1 (3.7%) |
3 (4.6%) |
0 (0%) |
0.03 | |